BAUSCH + LOMB CORP (BLCO) Fundamental Analysis & Valuation

NYSE:BLCO • CA0717051076

Current stock price

15.84 USD
-0.18 (-1.12%)
Last:

This BLCO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BLCO Profitability Analysis

1.1 Basic Checks

  • BLCO had positive earnings in the past year.
  • BLCO had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
  • Of the past 5 years BLCO 4 years had a positive operating cash flow.
BLCO Yearly Net Income VS EBIT VS OCF VS FCFBLCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of BLCO (-2.57%) is better than 69.57% of its industry peers.
  • Looking at the Return On Equity, with a value of -5.58%, BLCO is in the better half of the industry, outperforming 70.11% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 1.23%, BLCO is doing good in the industry, outperforming 67.39% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for BLCO is significantly below the industry average of 9.18%.
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROIC 1.23%
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
BLCO Yearly ROA, ROE, ROICBLCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 -4

1.3 Margins

  • Looking at the Operating Margin, with a value of 3.69%, BLCO is in the better half of the industry, outperforming 68.48% of the companies in the same industry.
  • BLCO's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 59.81%, BLCO is doing good in the industry, outperforming 60.33% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
Industry RankSector Rank
OM 3.69%
PM (TTM) N/A
GM 59.81%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
BLCO Yearly Profit, Operating, Gross MarginsBLCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1

2. BLCO Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLCO is destroying value.
  • BLCO has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BLCO has been increased compared to 5 years ago.
  • The debt/assets ratio for BLCO is higher compared to a year ago.
BLCO Yearly Shares OutstandingBLCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BLCO Yearly Total Debt VS Total AssetsBLCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • BLCO has an Altman-Z score of 0.86. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of BLCO (0.86) is comparable to the rest of the industry.
  • BLCO has a Debt/Equity ratio of 0.78. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
  • BLCO has a Debt to Equity ratio of 0.78. This is in the lower half of the industry: BLCO underperforms 70.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACC0.12
WACC9.97%
BLCO Yearly LT Debt VS Equity VS FCFBLCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that BLCO should not have too much problems paying its short term obligations.
  • BLCO's Current ratio of 1.55 is on the low side compared to the rest of the industry. BLCO is outperformed by 73.37% of its industry peers.
  • BLCO has a Quick Ratio of 1.04. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
  • BLCO has a Quick ratio of 1.04. This is in the lower half of the industry: BLCO underperforms 76.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.04
BLCO Yearly Current Assets VS Current LiabilitesBLCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. BLCO Growth Analysis

3.1 Past

  • The earnings per share for BLCO have decreased strongly by -19.35% in the last year.
  • The Revenue has been growing slightly by 6.47% in the past year.
  • The Revenue has been growing by 8.38% on average over the past years. This is quite good.
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 29.28% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, BLCO will show a small growth in Revenue. The Revenue will grow by 5.41% on average per year.
EPS Next Y61.57%
EPS Next 2Y47.88%
EPS Next 3Y40.86%
EPS Next 5Y29.28%
Revenue Next Year6.99%
Revenue Next 2Y6.25%
Revenue Next 3Y5.95%
Revenue Next 5Y5.41%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLCO Yearly Revenue VS EstimatesBLCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
BLCO Yearly EPS VS EstimatesBLCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0.5 1 1.5 2

4

4. BLCO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 31.68, which means the current valuation is very expensive for BLCO.
  • Based on the Price/Earnings ratio, BLCO is valued a bit cheaper than 72.28% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.79. BLCO is valued slightly more expensive when compared to this.
  • Based on the Price/Forward Earnings ratio of 19.61, the valuation of BLCO can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, BLCO is valued a bit cheaper than 77.17% of the companies in the same industry.
  • BLCO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.68
Fwd PE 19.61
BLCO Price Earnings VS Forward Price EarningsBLCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 75.54% of the companies in the same industry are more expensive than BLCO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.04
BLCO Per share dataBLCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BLCO's earnings are expected to grow with 40.86% in the coming years.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y47.88%
EPS Next 3Y40.86%

0

5. BLCO Dividend Analysis

5.1 Amount

  • BLCO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BLCO Fundamentals: All Metrics, Ratios and Statistics

BAUSCH + LOMB CORP

NYSE:BLCO (3/19/2026, 1:06:17 PM)

15.84

-0.18 (-1.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-18
Earnings (Next)N/A
Inst Owners10.27%
Inst Owner Change3.1%
Ins Owners0.48%
Ins Owner Change17.19%
Market Cap5.61B
Revenue(TTM)5.10B
Net Income(TTM)-360.00M
Analysts71.58
Price Target18.83 (18.88%)
Short Float %6.93%
Short Ratio6.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.14%
Min EPS beat(2)-10.76%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)-90.21%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)5
Avg EPS beat(8)-43.92%
EPS beat(12)8
Avg EPS beat(12)-25.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.28%
Revenue beat(8)2
Avg Revenue beat(8)-0.31%
Revenue beat(12)5
Avg Revenue beat(12)0.68%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.49%
PT rev (3m)7.6%
EPS NQ rev (1m)-28.97%
EPS NQ rev (3m)-46.1%
EPS NY rev (1m)0.36%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)0.73%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)1.13%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE 31.68
Fwd PE 19.61
P/S 1.1
P/FCF N/A
P/OCF 19.83
P/B 0.87
P/tB N/A
EV/EBITDA 17.04
EPS(TTM)0.5
EY3.16%
EPS(NY)0.81
Fwd EY5.1%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)0.8
OCFY5.04%
SpS14.4
BVpS18.2
TBVpS-4.49
PEG (NY)0.51
PEG (5Y)N/A
Graham Number14.31
Profitability
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROCE 1.55%
ROIC 1.23%
ROICexc 1.27%
ROICexgc 4.04%
OM 3.69%
PM (TTM) N/A
GM 59.81%
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
ROICexc(3y)1.38%
ROICexc(5y)1.81%
ROICexgc(3y)4.6%
ROICexgc(5y)6.09%
ROCE(3y)1.7%
ROCE(5y)2.22%
ROICexgc growth 3Y-15.27%
ROICexgc growth 5Y-11.42%
ROICexc growth 3Y-14.77%
ROICexc growth 5Y-9.61%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 8.28
Cap/Depr 82.9%
Cap/Sales 6.84%
Interest Coverage 0.49
Cash Conversion 46.47%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.04
Altman-Z 0.86
F-Score3
WACC9.97%
ROIC/WACC0.12
Cap/Depr(3y)65.67%
Cap/Depr(5y)57.94%
Cap/Sales(3y)5.76%
Cap/Sales(5y)5.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
EPS Next Y61.57%
EPS Next 2Y47.88%
EPS Next 3Y40.86%
EPS Next 5Y29.28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%
Revenue Next Year6.99%
Revenue Next 2Y6.25%
Revenue Next 3Y5.95%
Revenue Next 5Y5.41%
EBIT growth 1Y-7.39%
EBIT growth 3Y-8.57%
EBIT growth 5Y-6.91%
EBIT Next Year65.28%
EBIT Next 3Y27.94%
EBIT Next 5Y20.35%
FCF growth 1Y-11.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.98%
OCF growth 3Y-6.39%
OCF growth 5Y-11.52%

BAUSCH + LOMB CORP / BLCO Fundamental Analysis FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLCO.


What is the valuation status of BAUSCH + LOMB CORP (BLCO) stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.


What is the financial health of BAUSCH + LOMB CORP (BLCO) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.